The Senate voted 96-1 on Thursday to re-authorize the 1993 Prescription Drug User Fee Act, averting a downsizing of the FDA that could lengthen the approval process for getting important drugs and medical devices on the market.
PDUFA permits drug companies to provide funding for FDA resources to review and approve medications. The policy currently provides for a large portion of the agency’s budget for such activities.
Senators heralded the rare bipartisan spirit with which the bill sailed through the chamber. The only no-vote was Sen. Bernie Sander (I-VT). Partner legislation is expected to pass the House soon.
